On the basis of the first step of amplifying PCR, it has been hybridized with oligonucleotide microarray in order to analyze whether the amplified PCR product possess antimicrobial agent resistance or not.

• 摘要在第一步耐药性靶基因得到扩增的基础上，通过与芯片进行杂交来分析所扩增的PCR产物是否是已经发生了突变而能导致抗药性的基因。